Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200060364Phase 4Not yet recruiting
Phase 4, randomised trial of ropivacaine in Herniated Lumbar Disk (3 arms), sponsored by Shenzhen Traditional Chinese Medicine Hospital. Primary endpoints: Dosage of adjuvant intravenous analgesics and Lower limb muscle strength. Planned start May 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200060364.